Collagen & Gelatin Market

Collagen & Gelatin Market by Source (Bovine, Porcine, Marine), Application (Wound Care, Orthopedic, Cardiovascular Disease, Dental, Surgical, Dural), End User (Hospitals, Surgical Centers) and Region - Global Forecast to 2026

Report Code: BT 5488 Jul, 2021, by marketsandmarkets.com

[210 Pages Report] The global collagen and gelatin market is projected to reach USD 1,083 million by 2026 from USD 772 million in 2021, at a CAGR of 7.0% during the forecast period. Growth in the collagen and gelatin market is driven by factors such as the rising prevalence of target diseases and disorders, rising number of surgeries coupled with growing geriatric population, and investments in R&D. However, the availability of efficient and reliable substitute biomaterials is expected to restrain the market growth during the forecast period.

Collagen & Gelatin Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 impact on the collagen and gelatin market

Coronavirus disease 2019 (COVID‐19) is an acute respiratory infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Largely unknown before the outbreak began in Wuhan (China) in December 2019, COVID-19 has moved from a regional crisis to a global pandemic in just a few weeks. The World Health Organization (WHO) declared COVID-19 as a pandemic on March 11, 2020. Due to nationwide lockdowns, denied wound care services, and canceled or postponed elective surgeries, the collagen and gelatin market declined in 2020 and is expected to have this effect in 2021. Elective surgeries were being denied (canceled/postponed) to reserve or redirect the available limited capacities and resources (like hospital beds and patient care professionals) towards COVID-19 patient care.

Global the Collagen And Gelatin Market Dynamics

DRIVER: Growing incidence of diabetes, cancer, and chronic wounds

Diabetes is an important target indication—it can increase the incidence and complexity of wounds such as infections, ulcerations (leg or foot ulcers), and surgical wounds, requiring treatments and incurring exorbitant medical expenses. Nearly 25% of diabetics in the US develop foot ulcers during their lifetime, while ~15% of the diabetic population suffers from diabetic foot ulcers (DFUs). The increasing prevalence of DFUs is expected to drive the demand for regenerative medicine products like grafts and matrices. Thus, fueling the market growth.

RESTRAINTS: Availability of alternative biomaterials

The availability of efficient and reliable substitute biomaterials, which can heal, repair, or regenerate injured or diseased tissues and organs, is likely to restrain the market growth. Several biomaterials such as chitosan, alginate, cellulose, hyaluronic acid, polylactic acid (PLA), polyglycolic acid (PGA), and poly(lactic-co-glycolic acid) (PLGA) are used as alternatives for collagen and gelatin in regenerative medicine. Such substitutes may hinder the market growth across the globe.

OPPORTUNITY: Implementation of the 21st Century Cures Act

The 21st Century Cures Act was signed into law in the US in December 2016. The Act is designed to help accelerate medical product development and bring innovations and advances to patients who need them faster and efficiently. Under this Act, a new Regenerative Medicine Advanced Therapy designation has been established, along with a fast-track approval pathway for new regenerative medicine products. Considering this, the implementation of this Act can potentially result in the approval of new regenerative medicine products in the US and stimulate R&D in the field of regenerative medicine.

The orthopedic segment dominated the collagen and gelatin market in 2020:

Based on application, the global collagen market is segmented into orthopedic, wound care, dental, surgical, cardiovascular, and other applications. The global gelatin market is segmented into orthopedic, wound care and others. The orthopedic segment accounted for the largest share of 37.5% of the collagen market and  41.5% of the gelatin market in 2020, mainly due to the increasing use of these biomaterials in orthopedic surgeries and the high demand for scaffolds for bone substitutes.

The hospitals segment accounted for the largest share in 2020

Based on end users, the collagen and gelatin market is segmented into hospitals and surgical centers. In 2020, the hospitals segment accounted for the largest share of 80.6% of both collagen and gelatin markets. The large share of this market segment is mainly because most surgical procedures worldwide are performed in hospitals due to the availability of advanced facilities and equipment and skilled surgeons.

Collagen & Gelatin Market by Region

To know about the assumptions considered for the study, download the pdf brochure

North America was the largest regional market for collagen and gelatin in 2020.

Geographically, the collagen and gelatin markets is segmented into North America, Europe, Asia Pacific, RoW. In 2020, North America accounted for the largest share of the collagen and gelatin market, followed by Europe & Asia Pacific. The market in North America is largely driven by the presence of key market players in the region coupled with the rising geriatric population.

Key Market Players

Key players in the collagen and gelatin markets include Integra LifeSciences (US), Royal DSM (Netherlands), CollPlant Biotechnologies (Israel), Nitta Gelatin Inc. (Japan), Collagen Solutions plc (UK), Collagen Matrix, Inc. (US), Symatese (France), GELITA AG (Germany), PB Leiner (Belgium), Smith & Nephew (UK), Zimmer Biomet (US).

Scope of the report

Report Metric

Details

Market size available for years

2019–2026

Base year considered

2020

Forecast period

2021–2026

Forecast units

Value (USD Million)

Segments covered

Source, Application, End user and Region

Geographies covered

North America, Europe, Asia Pacific, Rest of the World

Companies covered

Integra Lifesciences (US), Royal DSM (Netherlands), Collplant Biotechnologies (israel), Nitta Gelatin Inc. (Japan), Collagen Solutions PLC (UK), Collagen Matrix, Inc. (US), Symatese (France), Gelita AG (Germany), PB Leiner (Belgium), Smith & Nephew (UK), Zimmer Biomet (US), Jellagen (UK), Advanced BioMatrix (US), Matricel GmbH (Germany),  Rousselot (Netherlands), WEISHARDT  (France), Xiamen Hyfine Gelatin  (China), Geistlich Pharma AG (Switzerland), Synerheal Pharmaceuticals (India),  Bioregen Technologies (India), Meril Lifesciences (India), MedSkin Solutions Dr. Suwelack AG (Germany), Cologenesis Healthcare Pvt Ltd  (India), DermaRite Industries, LL (US), Eucare Pharmaceuticals Private Limited  (India)

This report categorizes the collagen and gelatin market into the following segments and subsegments:

Collagen and Gelatin Market, by Source

  • Bovine
  • Porcine
  • Other sources

Collagen Market, by Application

  • Orthopedic
  • Wound Care
  • Dental
  • Surgical
  • Cardiovascular Disease
  • Others

Gelatin Market, by Application

  • Orthopedic
  • Wound Care
  • Other Applications

Collagen and Gelatin Market, by End users

  • Hospitals
  • Surgical Centers

Collagen and Gelatin Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Rest of Europe (RoE)
  • Asia Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of Asia Pacific (RoAPAC)
  • Rest of the World (RoW)
    • Latin America
    • MEA

Recent Developments

  • In January 2021, Integra LifeSciences completed the acquisition of ACell. This acquisition enabled the company to provide more comprehensive complex wound management solutions.
  • In September 2020, DSM partnered with PBC BioMed to develop regenerative bone adhesives for safer, more cost-effective surgical procedures.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 29)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS & EXCLUSIONS
                    TABLE 1 COLLAGEN AND GELATIN MARKET: INCLUSIONS & EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
                    FIGURE 1 COLLAGEN AND GELATIN MARKET SEGMENTATION
           1.3.2 YEARS CONSIDERED FOR THE STUDY
                    FIGURE 2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 34)
    2.1 RESEARCH APPROACH
           FIGURE 3 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
                    FIGURE 4 BREAKDOWN OF PRIMARIES: COLLAGEN AND GELATIN MARKET
           2.1.3 MARKET DATA ESTIMATION & TRIANGULATION
                    FIGURE 5 DATA TRIANGULATION METHODOLOGY
    2.2 MARKET ESTIMATION METHODOLOGY
           FIGURE 6 MARKET SIZE ESTIMATION APPROACH: TOP-DOWN
           FIGURE 7 COLLAGEN AND GELATIN MARKET: FINAL MARKET SIZE (USD MILLION)
    2.3 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
           FIGURE 8 GROWTH RATE ASSUMPTION BASED ON MARKET DYNAMICS
           FIGURE 9 FINAL CAGR PROJECTIONS (2021−2026)
    2.4 INSIGHTS FROM PRIMARIES
           FIGURE 10 MARKET VALIDATION FROM PRIMARY EXPERTS
    2.5 RESEARCH ASSUMPTIONS
    2.6 RISK ASSESSMENT
           TABLE 2 RISK ASSESSMENT

3 EXECUTIVE SUMMARY (Page No. - 42)
    FIGURE 11 COLLAGEN AND GELATIN SHARE, BY SOURCE, 2020 VS. 2026
    FIGURE 12 COLLAGEN MARKET SHARE, BY APPLICATION, 2020
    FIGURE 13 GELATIN MARKET SHARE, BY APPLICATION, 2020
    FIGURE 14 COLLAGEN AND GELATIN MARKET SHARE, BY END USER, 2020
    FIGURE 15 GEOGRAPHICAL SNAPSHOT OF THE COLLAGEN AND GELATIN MARKET

4 PREMIUM INSIGHTS (Page No. - 46)
    4.1 COLLAGEN AND GELATIN MARKET OVERVIEW
           FIGURE 16 GROWING INCIDENCE OF DIABETES, CANCER, AND CHRONIC WOUNDS TO DRIVE MARKET GROWTH
    4.2 NORTH AMERICA: COLLAGEN AND GELATIN MARKET SHARE,  BY SOURCE & COUNTRY (2020)
           FIGURE 17 BOVINE ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN COLLAGEN AND GELATIN MARKET IN 2020
    4.3 COLLAGEN MARKET SHARE, BY APPLICATION (2020)
           FIGURE 18 ORTHOPEDIC HELD THE DOMINANT SHARE OF THE MARKET IN 2020
    4.4 GELATIN MARKET SHARE, BY APPLICATION (2020)
           FIGURE 19 THE ORTHOPEDIC SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET IN 2020
    4.5 COLLAGEN: GEOGRAPHIC GROWTH OPPORTUNITIES
           FIGURE 20 EUROPE TO REGISTER THE HIGHEST GROWTH IN THE COLLAGEN MARKET DURING THE FORECAST PERIOD
    4.6 GELATIN: GEOGRAPHIC GROWTH OPPORTUNITIES
           FIGURE 21 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH IN THE GELATIN MARKET DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 51)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           FIGURE 22 COLLAGEN AND GELATIN MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
           5.2.1 IMPACT ANALYSIS
                    TABLE 3 COLLAGEN AND GELATIN MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, AND OPPORTUNITIES
           5.2.2 DRIVERS
                    5.2.2.1 Growing incidence of diabetes, cancer, and chronic wounds
                    5.2.2.2 Rising funding and investments for R&D
                    5.2.2.3 Growing number of surgical procedures
                                TABLE 4 PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED IN THE US
           5.2.3 RESTRAINTS
                    5.2.3.1 Availability of alternative biomaterials
           5.2.4 OPPORTUNITIES
                    5.2.4.1 Implementation of the 21st Century Cures Act
    5.3 RANGES/SCENARIOS
           FIGURE 23 DEPENDING ON HOW THE UNCERTAINTIES UNFOLD, WE SEE A SPECTRUM OF SCENARIOS FOR THE COLLAGEN AND GELATIN MARKET – 2026
    5.4 IMPACT OF THE COVID-19 PANDEMIC ON THE COLLAGEN AND GELATIN MARKET
           FIGURE 24 PRE-COVID-19 VS POST-COVID-19 SCENARIO
    5.5 YC–YCC SHIFT
           FIGURE 25 YC–YCC SHIFT FOR THE COLLAGEN AND GELATIN
    5.6 VALUE CHAIN ANALYSIS
           FIGURE 26 VALUE CHAIN OF THE COLLAGEN AND GELATIN MARKET
    5.7 SUPPLY CHAIN
           FIGURE 27 SUPPLY CHAIN OF COLLAGEN AND GELATIN MARKET
    5.8 ECOSYSTEM ANALYSIS
    5.9 TECHNOLOGY ANALYSIS
    5.10 PORTER’S FIVE FORCES ANALYSIS
            TABLE 5 PORTER’S FIVE FORCES ANALYSIS OF THE COLLAGEN & GELATIN MARKET
           5.10.1 THREAT FROM NEW ENTRANTS
           5.10.2 THREAT OF SUBSTITUTES
           5.10.3 BARGAINING POWER OF SUPPLIERS
           5.10.4 BARGAINING POWER OF BUYERS
           5.10.5 INTENSITY OF COMPETITION RIVALRY
    5.11 REGULATORY ANALYSIS
    5.12 PATENT ANALYSIS
            FIGURE 28 PATENT GRANTED FOR COLLAGEN AND GELATIN IN THE LAST 10 YEARS
            TABLE 6 INDICATIVE LIST OF PATENTS IN THE COLLAGEN AND GELATIN MARKET

6 COLLAGEN AND GELATIN MARKET, BY SOURCE (Page No. - 70)
    6.1 INTRODUCTION
           TABLE 7 COLLAGEN MARKET, BY SOURCE, 2019–2026 (USD MILLION)
           TABLE 8 GELATIN MARKET, BY SOURCE, 2019–2026 (USD MILLION)
    6.2 BOVINE COLLAGEN & GELATIN
           6.2.1 RISING USAGE IN TISSUE ENGINEERING APPLICATIONS DRIVES MARKET GROWTH
                    TABLE 9 BOVINE COLLAGEN MARKET, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 10 NORTH AMERICA: BOVINE COLLAGEN MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 11 EUROPE: BOVINE COLLAGEN MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 12 APAC: BOVINE COLLAGEN MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 13 BOVINE GELATIN MARKET, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 14 NORTH AMERICA: BOVINE GELATIN MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 15 EUROPE: BOVINE GELATIN MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 16 APAC: BOVINE GELATIN MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    6.3 PORCINE COLLAGEN & GELATIN
           6.3.1 PORCINE COLLAGEN & GELATIN SEEING WIDE USAGE OWING TO LOW ALLERGIC RESPONSE AND BIOCOMPATIBILITY
                    TABLE 17 PORCINE COLLAGEN MARKET, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 18 NORTH AMERICA: PORCINE COLLAGEN MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
                    TABLE 19 EUROPE: PORCINE COLLAGEN MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 20 APAC: PORCINE COLLAGEN MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 21 PORCINE GELATIN MARKET, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 22 NORTH AMERICA: PORCINE GELATIN MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 23 EUROPE: PORCINE GELATIN MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 24 APAC: PORCINE GELATIN MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    6.4 OTHER COLLAGEN & GELATIN SOURCES
           TABLE 25 OTHER COLLAGEN SOURCES MARKET, BY REGION, 2019–2026 (USD MILLION)
           TABLE 26 NORTH AMERICA: OTHER COLLAGEN SOURCES MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
           TABLE 27 EUROPE: OTHER COLLAGEN SOURCES MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
           TABLE 28 APAC: OTHER COLLAGEN SOURCES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 29 OTHER GELATIN SOURCES MARKET, BY REGION, 2019–2026 (USD MILLION)
           TABLE 30 NORTH AMERICA: OTHER GELATIN SOURCES MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
           TABLE 31 EUROPE: OTHER GELATIN SOURCES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 32 APAC: OTHER GELATIN SOURCES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)

7 COLLAGEN MARKET, BY APPLICATION (Page No. - 82)
    7.1 INTRODUCTION
           TABLE 33 COLLAGEN MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
    7.2 ORTHOPEDIC APPLICATIONS
           7.2.1 INCREASING USE OF COLLAGEN IN ORTHOPEDIC SURGERIES TO DRIVE GROWTH IN THIS MARKET SEGMENT
                    TABLE 34 COLLAGEN MARKET FOR ORTHOPEDIC APPLICATIONS, BY REGION,  2019–2026 (USD MILLION)
                    TABLE 35 NORTH AMERICA: COLLAGEN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 36 EUROPE: COLLAGEN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY,  2019–2026 (USD MILLION)
                    TABLE 37 APAC: COLLAGEN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY,  2019–2026 (USD MILLION)
    7.3 WOUND CARE APPLICATIONS
           7.3.1 RISING PREVALENCE OF CHRONIC CONDITIONS TO DRIVE THE GROWTH OF THIS SEGMENT
                    TABLE 38 COLLAGEN MARKET FOR WOUND CARE APPLICATIONS, BY REGION,  2019–2026 (USD MILLION)
                    TABLE 39 NORTH AMERICA: COLLAGEN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 40 EUROPE: COLLAGEN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY,  2019–2026 (USD MILLION)
                    TABLE 41 APAC: COLLAGEN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY,  2019–2026 (USD MILLION)
    7.4 DENTAL APPLICATIONS
           7.4.1 RISING INCIDENCE OF ORAL DISORDERS TO DRIVE MARKET GROWTH
                    TABLE 42 COLLAGEN MARKET FOR DENTAL APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 43 NORTH AMERICA: COLLAGEN MARKET FOR DENTAL APPLICATIONS, BY COUNTRY,  2019–2026 (USD MILLION)
                    TABLE 44 EUROPE: COLLAGEN MARKET FOR DENTAL APPLICATIONS, BY COUNTRY,  2019–2026 (USD MILLION)
                    TABLE 45 APAC: COLLAGEN MARKET FOR DENTAL APPLICATIONS, BY COUNTRY,  2019–2026 (USD MILLION)
    7.5 SURGICAL APPLICATIONS
           7.5.1 INCREASING NUMBER OF SURGICAL PROCEDURES ACROSS THE GLOBE TO BOOST THE DEMAND FOR COLLAGEN-BASED PRODUCTS
                    TABLE 46 COLLAGEN MARKET FOR SURGICAL APPLICATIONS, BY REGION,  2019–2026 (USD MILLION)
                    TABLE 47 NORTH AMERICA: COLLAGEN MARKET FOR SURGICAL APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 48 EUROPE: COLLAGEN MARKET FOR SURGICAL APPLICATIONS, BY COUNTRY,  2019–2026 (USD MILLION)
                    TABLE 49 APAC: COLLAGEN MARKET FOR SURGICAL APPLICATIONS, BY COUNTRY,  2019–2026 (USD MILLION)
    7.6 CARDIOVASCULAR APPLICATIONS
           7.6.1 APPLICATION OF COLLAGEN IN THE TREATMENT OF CVDS HAS GARNERED SIGNIFICANT INTEREST DUE TO A LACK OF EFFECTIVE THERAPIES
                    TABLE 50 COLLAGEN MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION,  2019–2026 (USD MILLION)
                    TABLE 51 NORTH AMERICA: COLLAGEN MARKET FOR CARDIOVASCULAR APPLICATIONS,  BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 52 EUROPE: COLLAGEN MARKET FOR CARDIOVASCULAR APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 53 APAC: COLLAGEN MARKET FOR CARDIOVASCULAR APPLICATIONS, BY COUNTRY,  2019–2026 (USD MILLION)
    7.7 OTHER APPLICATIONS
           TABLE 54 COLLAGEN MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
           TABLE 55 NORTH AMERICA: COLLAGEN MARKET FOR OTHER APPLICATIONS, BY COUNTRY,  2019–2026 (USD MILLION)
           TABLE 56 EUROPE: COLLAGEN MARKET FOR OTHER APPLICATIONS, BY COUNTRY,  2019–2026 (USD MILLION)
           TABLE 57 APAC: COLLAGEN MARKET FOR OTHER APPLICATIONS, BY COUNTRY,  2019–2026 (USD MILLION)

8 GELATIN MARKET, BY APPLICATION (Page No. - 96)
    8.1 INTRODUCTION
           TABLE 58 GELATIN MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
    8.2 ORTHOPEDIC APPLICATIONS
           8.2.1 INTRODUCTION OF NOVEL THERAPIES USING GELATIN FOR REGENERATING BONE AND CARTILAGE TO DRIVE THE DEMAND FOR GELATIN IN THIS APPLICATION SEGMENT
                    TABLE 59 GELATIN MARKET FOR ORTHOPEDIC APPLICATIONS, BY REGION,  2019–2026 (USD MILLION)
                    TABLE 60 NORTH AMERICA: GELATIN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 61 EUROPE: GELATIN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY,  2019–2026 (USD MILLION)
                    TABLE 62 APAC: GELATIN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY,  2019–2026 (USD MILLION)
    8.3 WOUND CARE APPLICATIONS
           8.3.1 APPLICATION OF GELATIN HYDROGELS IN THE TREATMENT OF BURNS TO DRIVE MARKET GROWTH
                    TABLE 63 GELATIN MARKET FOR WOUND CARE APPLICATIONS, BY REGION,  2019–2026 (USD MILLION)
                    TABLE 64 NORTH AMERICA: GELATIN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 65 EUROPE: GELATIN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY,  2019–2026 (USD MILLION)
                    TABLE 66 APAC: GELATIN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY,  2019–2026 (USD MILLION)
    8.4 OTHER APPLICATIONS
           TABLE 67 GELATIN MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
           TABLE 68 NORTH AMERICA: GELATIN MARKET FOR OTHER APPLICATIONS, BY COUNTRY,  2019–2026 (USD MILLION)
           TABLE 69 EUROPE: GELATIN MARKET FOR OTHER APPLICATIONS, BY COUNTRY,  2019–2026 (USD MILLION)
           TABLE 70 APAC: GELATIN MARKET FOR OTHER APPLICATIONS, BY COUNTRY,  2019–2026 (USD MILLION)

9 COLLAGEN AND GELATIN MARKET, BY END USER (Page No. - 103)
    9.1 INTRODUCTION
           TABLE 71 COLLAGEN MARKET, BY END USER, 2019–2026 (USD MILLION)
           TABLE 72 GELATIN MARKET, BY END USER, 2019–2026 (USD MILLION)
    9.2 HOSPITALS
           9.2.1 HOSPITALS ARE THE LARGEST END USERS OF BIOSURGERY PRODUCTS—A KEY FACTOR DRIVING MARKET GROWTH
                    TABLE 73 COLLAGEN MARKET FOR HOSPITALS, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 74 NORTH AMERICA: COLLAGEN MARKET FOR HOSPITALS, BY COUNTRY,  2019–2026 (USD MILLION)
                    TABLE 75 EUROPE: COLLAGEN MARKET FOR HOSPITALS, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 76 APAC: COLLAGEN MARKET FOR HOSPITALS, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 77 GELATIN MARKET FOR HOSPITALS, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 78 NORTH AMERICA: GELATIN MARKET FOR HOSPITALS, BY COUNTRY,  2019–2026 (USD MILLION)
                    TABLE 79 EUROPE: GELATIN MARKET FOR HOSPITALS, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 80 APAC: GELATIN MARKET FOR HOSPITALS, BY COUNTRY, 2019–2026 (USD MILLION)
    9.3 SURGICAL CENTERS
           9.3.1 SURGICAL CENTERS HAVE EMERGED AS A SIGNIFICANT END USER DUE TO THEIR ABILITY TO IMPROVE QUALITY AND CUSTOMER SERVICE WHILE SIMULTANEOUSLY REDUCING COSTS
                    TABLE 81 COLLAGEN MARKET FOR SURGICAL CENTERS, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 82 NORTH AMERICA: COLLAGEN MARKET FOR SURGICAL CENTERS, BY COUNTRY,  2019–2026 (USD MILLION)
                    TABLE 83 EUROPE: COLLAGEN MARKET FOR SURGICAL CENTERS, BY COUNTRY,  2019–2026 (USD MILLION)
                    TABLE 84 APAC: COLLAGEN MARKET FOR SURGICAL CENTERS, BY COUNTRY,  2019–2026 (USD MILLION)
                    TABLE 85 GELATIN MARKET FOR SURGICAL CENTERS, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 86 NORTH AMERICA: GELATIN MARKET FOR SURGICAL CENTERS, BY COUNTRY,  2019–2026 (USD MILLION)
                    TABLE 87 EUROPE: GELATIN MARKET FOR SURGICAL CENTERS, BY COUNTRY,  2019–2026 (USD MILLION)
                    TABLE 88 APAC: GELATIN MARKET FOR SURGICAL CENTERS, BY COUNTRY,  2019–2026 (USD MILLION)

10 COLLAGEN AND GELATIN MARKET, BY REGION (Page No. - 112)
     10.1 INTRODUCTION
             FIGURE 29 COLLAGEN MARKET: REGIONAL SNAPSHOT (2021 VS. 2026)
             FIGURE 30 GELATIN MARKET: REGIONAL SNAPSHOT (2021 VS. 2026)
             TABLE 89 COLLAGEN MARKET, BY REGION, 2019–2026 (USD MILLION)
             TABLE 90 GELATIN MARKET, BY REGION, 2019–2026 (USD MILLION)
     10.2 NORTH AMERICA
             FIGURE 31 NORTH AMERICA: COLLAGEN MARKET SNAPSHOT
             TABLE 91 NORTH AMERICA: COLLAGEN MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
             TABLE 92 NORTH AMERICA: COLLAGEN MARKET, BY SOURCE, 2019–2026 (USD MILLION)
             TABLE 93 NORTH AMERICA: COLLAGEN MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
             TABLE 94 NORTH AMERICA: COLLAGEN MARKET, BY END USER, 2019–2026 (USD MILLION)
             FIGURE 32 NORTH AMERICA: GELATIN MARKET SNAPSHOT
             TABLE 95 NORTH AMERICA: GELATIN MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
             TABLE 96 NORTH AMERICA: GELATIN MARKET, BY SOURCE, 2019–2026 (USD MILLION)
             TABLE 97 NORTH AMERICA: GELATIN MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
             TABLE 98 NORTH AMERICA: GELATIN MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.2.1 US
                        10.2.1.1 Increasing incidence of periodontitis and burn injuries to boost market growth in the US
                                     TABLE 99 US: COLLAGEN MARKET, BY SOURCE, 2019–2026 (USD MILLION)
                                     TABLE 100 US: COLLAGEN MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                     TABLE 101 US: COLLAGEN MARKET, BY END USER, 2019–2026 (USD MILLION)
                                     TABLE 102 US: GELATIN MARKET, BY SOURCE, 2019–2026 (USD MILLION)
             10.2.2 CANADA
                        10.2.2.1 Growing geriatric population and increasing volume of surgeries to drive the demand for collagen and gelatin products in Canada
                                     TABLE 103 CANADA: COLLAGEN MARKET, BY SOURCE, 2019–2026 (USD MILLION)
                                     TABLE 104 CANADA: COLLAGEN MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                     TABLE 105 CANADA: COLLAGEN MARKET, BY END USER, 2019–2026 (USD MILLION)
                                     TABLE 106 CANADA: GELATIN MARKET, BY SOURCE, 2019–2026 (USD MILLION)
                                     TABLE 107 CANADA: GELATIN MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                     TABLE 108 CANADA: GELATIN MARKET, BY END USER, 2019–2026 (USD MILLION)
     10.3 EUROPE
             TABLE 109 EUROPE: COLLAGEN MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
             TABLE 110 EUROPE: COLLAGEN MARKET, BY SOURCE, 2019–2026 (USD MILLION)
             TABLE 111 EUROPE: COLLAGEN MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
             TABLE 112 EUROPE: COLLAGEN MARKET, BY END USER, 2019–2026 (USD MILLION)
             TABLE 113 EUROPE: GELATIN MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
             TABLE 114 EUROPE: GELATIN MARKET, BY SOURCE, 2019–2026 (USD MILLION)
             TABLE 115 EUROPE: GELATIN MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
             TABLE 116 EUROPE: GELATIN MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.3.1 GERMANY
                        10.3.1.1 Increase in healthcare expenditure to support the adoption of collagen and gelatin products
                                     TABLE 117 GERMANY: COLLAGEN MARKET, BY SOURCE, 2019–2026 (USD MILLION)
                                     TABLE 118 GERMANY: COLLAGEN MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                     TABLE 119 GERMANY: COLLAGEN MARKET, BY END USER, 2019–2026 (USD MILLION)
                                     TABLE 120 GERMANY: GELATIN MARKET, BY SOURCE, 2019–2026 (USD MILLION)
                                     TABLE 121 GERMANY: GELATIN MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                     TABLE 122 GERMANY: GELATIN MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.3.2 UK
                        10.3.2.1 Increasing incidence of chronic wounds and growing focus on R&D to drive market growth in the UK
                                     TABLE 123 UK: COLLAGEN MARKET, BY SOURCE, 2019–2026 (USD MILLION)
                                     TABLE 124 UK: COLLAGEN MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                     TABLE 125 UK: COLLAGEN MARKET, BY END USER, 2019–2026 (USD MILLION)
                                     TABLE 126 UK: GELATIN MARKET, BY SOURCE, 2019–2026 (USD MILLION)
                                     TABLE 127 UK: GELATIN MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                     TABLE 128 UK: GELATIN MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.3.3 FRANCE
                        10.3.3.1 Presence of a well-established healthcare system and growing geriatric population to boost market growth
                                     TABLE 129 FRANCE: COLLAGEN MARKET, BY SOURCE, 2019–2026 (USD MILLION)
                                     TABLE 130 FRANCE: COLLAGEN MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                     TABLE 131 FRANCE: COLLAGEN MARKET, BY END USER, 2019–2026 (USD MILLION)
                                     TABLE 132 FRANCE: GELATIN MARKET, BY SOURCE, 2019–2026 (USD MILLION)
                                     TABLE 133 FRANCE: GELATIN MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                     TABLE 134 FRANCE: GELATIN MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.3.4 REST OF EUROPE
                        TABLE 135 ROE: COLLAGEN MARKET, BY SOURCE, 2019–2026 (USD MILLION)
                        TABLE 136 ROE: COLLAGEN MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                        TABLE 137 ROE: COLLAGEN MARKET, BY END USER, 2019–2026 (USD MILLION)
                        TABLE 138 ROE: GELATIN MARKET, BY SOURCE, 2019–2026 (USD MILLION)
                        TABLE 139 ROE: GELATIN MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                        TABLE 140 ROE: GELATIN MARKET, BY END USER, 2019–2026 (USD MILLION)
     10.4 ASIA PACIFIC
             FIGURE 33 ASIA PACIFIC: COLLAGEN MARKET SNAPSHOT
             TABLE 141 ASIA PACIFIC: COLLAGEN MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
             TABLE 142 ASIA PACIFIC: COLLAGEN MARKET, BY SOURCE, 2019–2026 (USD MILLION)
             TABLE 143 ASIA PACIFIC: COLLAGEN MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
             TABLE 144 ASIA PACIFIC: COLLAGEN MARKET, BY END USER, 2019–2026 (USD MILLION)
             FIGURE 34 ASIA PACIFIC: GELATIN MARKET SNAPSHOT
             TABLE 145 ASIA PACIFIC: GELATIN MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
             TABLE 146 ASIA PACIFIC: GELATIN MARKET, BY SOURCE, 2019–2026 (USD MILLION)
             TABLE 147 ASIA PACIFIC: GELATIN MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
             TABLE 148 ASIA PACIFIC: GELATIN MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.4.1 JAPAN
                        10.4.1.1 Strong healthcare system and rising geriatric population to support market growth in Japan
                                     TABLE 149 JAPAN: COLLAGEN MARKET, BY SOURCE, 2019–2026 (USD MILLION)
                                     TABLE 150 JAPAN: COLLAGEN MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                     TABLE 151 JAPAN: COLLAGEN MARKET, BY END USER, 2019–2026 (USD MILLION)
                                     TABLE 152 JAPAN: GELATIN MARKET, BY SOURCE, 2019–2026 (USD MILLION)
                                     TABLE 153 JAPAN: GELATIN MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                     TABLE 154 JAPAN: GELATIN MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.4.2 CHINA
                        10.4.2.1 Growing number of hospitals stimulating the growth of the market
                                     TABLE 155 CHINA: COLLAGEN MARKET, BY SOURCE, 2019–2026 (USD MILLION)
                                     TABLE 156 CHINA: COLLAGEN MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                     TABLE 157 CHINA: COLLAGEN MARKET, BY END USER, 2019–2026 (USD MILLION)
                                     TABLE 158 CHINA: GELATIN MARKET, BY SOURCE, 2019–2026 (USD MILLION)
                                     TABLE 159 CHINA: GELATIN MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                     TABLE 160 CHINA: GELATIN MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.4.3 INDIA
                        10.4.3.1 Rising healthcare awareness and favorable government support to stimulate market growth in India
                                     TABLE 161 INDIA: COLLAGEN MARKET, BY SOURCE, 2019–2026 (USD MILLION)
                                     TABLE 162 INDIA: COLLAGEN MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                     TABLE 163 INDIA: COLLAGEN MARKET, BY END USER, 2019–2026 (USD MILLION)
                                     TABLE 164 INDIA: GELATIN MARKET, BY SOURCE, 2019–2026 (USD MILLION)
                                     TABLE 165 INDIA: GELATIN MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                     TABLE 166 INDIA: GELATIN MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.4.4 REST OF ASIA PACIFIC
                       TABLE 167 ROAPAC: COLLAGEN MARKET, BY SOURCE, 2019–2026 (USD MILLION)
                       TABLE 168 ROAPAC: COLLAGEN MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                       TABLE 169 ROAPAC: COLLAGEN MARKET, BY END USER, 2019–2026 (USD MILLION)
                       TABLE 170 ROAPAC: GELATIN MARKET, BY SOURCE, 2019–2026 (USD MILLION)
                       TABLE 171 ROAPAC: GELATIN MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                       TABLE 172 ROAPAC: GELATIN MARKET, BY END USER, 2019–2026 (USD MILLION)
     10.5 REST OF THE WORLD
             TABLE 173 ROW: COLLAGEN MARKET, BY REGION, 2019–2026 (USD MILLION)
             TABLE 174 ROW: COLLAGEN MARKET, BY SOURCE, 2019–2026 (USD MILLION)
             TABLE 175 ROW: COLLAGEN MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
             TABLE 176 ROW: COLLAGEN MARKET, BY END USER, 2019–2026 (USD MILLION)
             TABLE 177 ROW: GELATIN MARKET, BY SOURCE, 2019–2026 (USD MILLION)
             TABLE 178 ROW: GELATIN MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
             TABLE 179 ROW: GELATIN MARKET, BY END USER, 2019–2026 (USD MILLION)
     10.6 LATIN AMERICA
             10.6.1 INCREASING PREVALENCE OF DIABETES TO DRIVE MARKET GROWTH IN LATIN AMERICA
                       TABLE 180 LATIN AMERICA: COLLAGEN MARKET, BY SOURCE, 2019–2026 (USD MILLION)
                       TABLE 181 LATIN AMERICA: COLLAGEN MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                       TABLE 182 LATIN AMERICA: COLLAGEN MARKET, BY END USER, 2019–2026 (USD MILLION)
     10.7 MIDDLE EAST & AFRICA
             10.7.1 HEALTHCARE INFRASTRUCTURE IMPROVEMENTS TO DRIVE MARKET GROWTH
                       TABLE 183 MEA: COLLAGEN MARKET, BY SOURCE, 2019–2026 (USD MILLION)
                       TABLE 184 MEA: COLLAGEN MARKET, BY END USER, 2019–2026 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 157)
     11.1 INTRODUCTION
     11.2 KEY STRATEGIES ADOPTED BY PLAYERS IN THE COLLAGEN AND GELATIN MARKET
     11.3 REVENUE ANALYSIS
             FIGURE 35 REVENUE ANALYSIS FOR THE KEY PLAYERS IN THE COLLAGEN AND GELATIN MARKET
     11.4 MARKET RANKING
             FIGURE 36 COLLAGEN AND GELATIN MARKET: MARKET RANKING OF KEY PLAYERS (2020)
     11.5 COMPANY EVALUATION QUADRANT
             11.5.1 STARS
             11.5.2 EMERGING LEADERS
             11.5.3 PERVASIVE PLAYERS
             11.5.4 PARTICIPANTS
                        FIGURE 37 COLLAGEN AND GELATIN MARKET: COMPANY EVALUATION QUADRANT, 2020
     11.6 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES
             11.6.1 PROGRESSIVE COMPANIES
             11.6.2 STARTING BLOCKS
             11.6.3 RESPONSIVE COMPANIES
             11.6.4 DYNAMIC COMPANIES
                        FIGURE 38 COLLAGEN AND GELATIN MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2020
     11.7 COMPETITIVE BENCHMARKING
             11.7.1 COMPANY PRODUCT FOOTPRINT
             11.7.2 COMPANY INDUSTRY FOOTPRINT
             11.7.3 COMPANY REGIONAL FOOTPRINT
             11.7.4 COMPANY APPLICATION FOOTPRINT
     11.8 GROWTH STRATEGIES ADOPTED BY MAJOR AND EMERGING PLAYERS
             11.8.1 COLLAGEN AND GELATIN MARKET: PRODUCT LAUNCHES (JANUARY 2018–JUNE 2021)
             11.8.2 COLLAGEN AND GELATIN MARKET: KEY DEALS  (JANUARY 2018–JUNE 2021)
             11.8.3 COLLAGEN AND GELATIN MARKET: OTHER DEVELOPMENTS (JANUARY 2018–JUNE 2021)

12 COMPANY PROFILES (Page No. - 169)
     12.1 KEY COMPANIES
(Business Overview, Products Offered, Recent Developments, MnM View)*
             12.1.1 INTEGRA LIFESCIENCES
                        TABLE 185 INTEGRA LIFESCIENCES: BUSINESS OVERVIEW
                        FIGURE 39 INTEGRA LIFESCIENCES: COMPANY SNAPSHOT (2020)
                        TABLE 186 INTEGRA LIFESCIENCES: PRODUCT OFFERINGS
                        TABLE 187 INTEGRA LIFESCIENCES: DEALS
             12.1.2 ROYAL DSM
                        TABLE 188 ROYAL DSM: BUSINESS OVERVIEW
                        FIGURE 40 ROYAL DSM: COMPANY SNAPSHOT (2020)
                        TABLE 189 ROYAL DSM: PRODUCT OFFERINGS
                        TABLE 190 ROYAL DSM: DEALS
             12.1.3 COLLPLANT BIOTECHNOLOGIES LTD.
                        TABLE 191 COLLPLANT BIOTECHNOLOGIES LTD.: BUSINESS OVERVIEW
                        FIGURE 41 COLLPLANT BIOTECHNOLOGIES LTD.: COMPANY SNAPSHOT (2020)
                        TABLE 192 COLLPLANT BIOTECHNOLOGIES LTD.: PRODUCT OFFERINGS
                        TABLE 193 COLLPLANT BIOTECHNOLOGIES LTD.: DEALS
             12.1.4 NITTA GELATIN INC.
                        TABLE 194 NITTA GELATIN INC.: BUSINESS OVERVIEW
                        FIGURE 42 NITTA GELATIN INC.: COMPANY SNAPSHOT (2020)
                        TABLE 195 NITTA GELATIN INC.: PRODUCT OFFERINGS
             12.1.5 COLLAGEN SOLUTIONS PLC
                        TABLE 196 COLLAGEN SOLUTIONS PLC: BUSINESS OVERVIEW
                        FIGURE 43 COLLAGEN SOLUTIONS PLC: COMPANY SNAPSHOT (2020)
                        TABLE 197 COLLAGEN SOLUTIONS: PRODUCT OFFERINGS
             12.1.6 COLLAGEN MATRIX, INC.
                        TABLE 198 COLLAGEN MATRIX, INC.: BUSINESS OVERVIEW
                        TABLE 199 COLLAGEN MATRIX, INC.: PRODUCT OFFERINGS
                        TABLE 200 COLLAGEN MATRIX, INC.: PRODUCT LAUNCHES
                        TABLE 201 COLLAGEN MATRIX, INC.: DEALS
                        TABLE 202 COLLAGEN MATRIX, INC.: OTHER DEVELOPMENTS
             12.1.7 SYMATESE
                        TABLE 203 SYMATESE: BUSINESS OVERVIEW
                        TABLE 204 SYMATESE: PRODUCT OFFERINGS
             12.1.8 GELITA AG
                        TABLE 205 GELITA AG: BUSINESS OVERVIEW
                        TABLE 206 GELITA AG: PRODUCT OFFERINGS
                        TABLE 207 GELITA AG: DEALS
             12.1.9 PB LEINER
                        TABLE 208 PB LEINER: BUSINESS OVERVIEW
                        TABLE 209 PB LEINER: PRODUCT OFFERINGS
                        TABLE 210 PB LEINER: DEALS
             12.1.10 SMITH & NEPHEW PLC
                        TABLE 211 SMITH & NEPHEW PLC: BUSINESS OVERVIEW
                        FIGURE 44 SMITH & NEPHEW PLC: COMPANY SNAPSHOT (2020)
                        TABLE 212 SMITH & NEPHEW PLC: PRODUCT OFFERINGS
             12.1.11 ZIMMER BIOMET
                        TABLE 213 ZIMMER BIOMET: BUSINESS OVERVIEW
                        FIGURE 45 ZIMMER BIOMET: COMPANY SNAPSHOT (2020)
                        TABLE 214 ZIMMER BIOMET: PRODUCT OFFERINGS
             12.1.12 JELLAGEN
                        TABLE 215 JELLAGEN: BUSINESS OVERVIEW
                        TABLE 216 JELLAGEN: PRODUCT OFFERINGS
     12.2 OTHER PLAYERS
             12.2.1 ADVANCED BIOMATRIX
                        TABLE 217 ADVANCED BIOMATRIX: COMPANY OVERVIEW
             12.2.2 MATRICEL GMBH
                        TABLE 218 MATRICEL GMBH: COMPANY OVERVIEW
             12.2.3 ROUSSELOT
                        TABLE 219 ROUSSELOT: COMPANY OVERVIEW
             12.2.4 WEISHARDT
                        TABLE 220 WEISHARDT: COMPANY OVERVIEW
             12.2.5 XIAMEN HYFINE GELATIN
                        TABLE 221 XIAMEN HYFINE GELATIN: COMPANY OVERVIEW
             12.2.6 GEISTLICH PHARMA AG
                        TABLE 222 GEISTLICH PHARMA AG: COMPANY OVERVIEW
             12.2.7 SYNERHEAL PHARMACEUTICALS
                        TABLE 223 SYNERHEAL PHARMACEUTICALS: COMPANY OVERVIEW
             12.2.8 BIOREGEN TECHNOLOGIES
                        TABLE 224 BIOREGEN TECHNOLOGIES: COMPANY OVERVIEW
             12.2.9 MERIL LIFE SCIENCES PVT. LTD.
                        TABLE 225 MERIL LIFE SCIENCES PVT. LTD.: COMPANY OVERVIEW
             12.2.10 MEDSKIN SOLUTIONS DR. SUWELACK
                        TABLE 226 MEDSKIN SOLUTIONS DR. SUWELACK: COMPANY OVERVIEW
             12.2.11 COLOGENESIS HEALTHCARE PVT. LTD.
                        TABLE 227 COLOGENESIS HEALTHCARE PVT. LTD.: COMPANY OVERVIEW
             12.2.12 DERMARITE INDUSTRIES, LLC
                        TABLE 228 DERMARITE INDUSTRIES, LLC: COMPANY OVERVIEW
             12.2.13 EUCARE PHARMACEUTICALS PRIVATE LIMITED
                        TABLE 229 EUCARE PHARMACEUTICALS PRIVATE LIMITED: COMPANY OVERVIEW

*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

13 APPENDIX (Page No. - 202)
     13.1 DISCUSSION GUIDE
     13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.3 AVAILABLE CUSTOMIZATIONS
     13.4 RELATED REPORTS
     13.5 AUTHOR DETAILS

This study involved four major activities in estimating the current size of the collagen and gelatin market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the collagen and gelatin market. Some of the key secondary sources referred to for this study include publications from government sources World Health Organization (WHO), US Food and Drug Administration (FDA), National Institutes of Health (NIH), National Center for Biotechnology Information (NCBI), Organisation for Economic Co-operation and Development (OECD), American Diabetes Association (ADA), Academy of Physicians in Wound Healing (APWH), American Academy and Board of Regenerative Medicine, Canadian Association for Research in Regenerative Medicine. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

Collagen & Gelatin Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the collagen and gelatin market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and market have been identified through extensive secondary research
  • The revenues generated from the collagen and gelatin business of leading players have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Report Objectives

  • To define, describe, and forecast the collagen and gelatin market based on source, application, end users and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and trends)
  • To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall collagen and gelatin market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, Rest of the World
  • To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the collagen and gelatin market.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Company Information

  • An additional five company profiles
COVID-19

Get in-depth analysis of the COVID-19 impact on the Collagen & Gelatin Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Collagen & Gelatin Market

Request For Special Pricing
Report Code
BT 5488
Published ON
Jul, 2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Collagen & Gelatin Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved